HLA-B*08:01 | easYmer kit
Product Code:
IMM-1050-01
IMM-1050-01
Regulatory Status:
RUO
RUO
Shipping:
Dry Ice
Dry Ice
Storage:
-20 °C
-20 °C
No additional charges, what you see is what you pay! *
Stay in control of your spending. These prices have no additional charges to UK mainland customers, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Denmark.
Typical lead time: 7-10 working days.
Contact us for more accurate information.
Typical lead time: 7-10 working days.
Contact us for more accurate information.
- Further Information
- References
- Show All
Further Information
Description:
HLA-Class I easYmer® is a highly active formulation of peptide-receptive HLA class I (HLA-I) molecules (no artificial Cys-bonds linking heavy chain and b2m). Add Peptides of interest to generate specific peptide-HLA class I monomers. The loading efficacy can be validated in a FACS-based bead assay. The monomers can easily be tetramerised with fluorophore-conjugated streptavidin and used to stain cognate T cells for analysis in a flow cytometric assay. The easYmer® technology seamlessly enables: Large-scale production of pMHC monomers with a single epitope for screening a large number of samples, parallel production and screening of pMHC monomers with many different peptide epitope candidates and screening and validation of peptide-HLA-I binding. easYmers® are available in aliquots of 50 Tests (corresponding to 20 ug of pMHC)
References
- Gerke, C; et.al.; Multimodal HLA-I genotype regulation by human cytomegalovirus US10 and resulting surface patterning; eLife; 2024; ():PubMed ID:; DOI: https://doi.org/10.7554/eLife.85560; https://elifesciences.org/articles/85560#content
- Ryu, H; et.al.; Merkel cell polyomavirus-specific and CD39+CLA+ CD8 T?cells as blood-based predictive biomarkers for PD-1 blockade in Merkel cell carcinoma; Cell reports. Medicine; 2024; 5(2):101390PubMed ID:38340724; DOI: 10.1016/j.xcrm.2023.101390; https://www.cell.com/cell-reports-medicine/pdf/S2666-3791(23)00619-5.pdf

